RanD Revenue and Competitors
Estimated Revenue & Valuation
- RanD's estimated annual revenue is currently $5.5M per year.
- RanD's estimated revenue per employee is $251,000
Employee Data
- RanD has 22 Employees.
- RanD grew their employee count by 5% last year.
RanD's People
| Name | Title | Email/Phone |
|---|
RanD Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is RanD?
Located in the internationally well-known Mirandola Bio-medical district, RanD is a knowledge-based company, established in 1999 exploiting more than 30 years' experience in the bio-medical field. Over the years RanD developed a whole range of products mainly focused on surgical oncology, but it also exploited its own know-how in the development of third-party cutting-edge projects in the fields of liver support, cardiopulmonary support and dialysis.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$5.5M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RanD News
A South African Rand is seen in this illustration picture taken October 30, 2020. REUTERS/Mike Hutchings/File Photo...
Some analysts say the rand's 2 percent slide against the US dollar is also due to the ongoing uncertainty around the Ukrainian/ Russian war and...
The rand weakened to the lowest in a month against the dollar on Tuesday at midday, as global growth amid the ongoing war in Ukraine and...
Other Companies in Medolla
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $74.5M | 251 | 5% | N/A |
#2 | $42.6M | 341 | 5% | N/A |